Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ZNQ
|
|||
| Former ID |
DIB001472
|
|||
| Drug Name |
Recombinant L-asparaginase
|
|||
| Synonyms |
ASPAREC; AZP-02; Recombinant L-asparaginase (acute lymphoblastic leukemia), OPi/EUSA; Recombinant L-asparaginase (PEGylated, long-acting, acute lymphoblastic leukemia); Recombinant L-asparaginase (PEGylated, long-acting, acute lymphoblastic leukemia), Alize Pharma
Click to Show/Hide
|
|||
| Indication | Acute lymphoblastic leukaemia [ICD-11: 2A85; ICD-10: C85.1, C88.7] | Investigative | [1] | |
| Company |
OPi SA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.